

To find out more about the AltoStar® Molecular Diagnostic Workflow, visit us at the ECCMID 2018 – 28th European Congress of Clinical Microbiology and Infectious Diseases, which will take place in Madrid, Spain, from 21 - 24 April 2018. About altona
altona Diagnostics, founded in 2007 and based in Hamburg, Germany, is focused on developing and manufacturing molecular diagnostic test systems for the detection and quantification of pathogens related to human infectious diseases. altona Diagnostics is ISO 13485 certified and manufactures under cGMP guidelines. Among other activities, altona Diagnostics was one of the first companies to make reliable molecular diagnostic kits commercially available during outbreak situations for SARS, EHEC, MERS, Ebolavirus and Zika virus. Source: altona Diagnostics GmbH Press Release from April 19th, 2018, http://www.altona-diagnostics.com/en/news/altona-diagnostics-launches-ce-ivd-marked-altostar-molecular-diagnostic-workflow.html
More News

Pacira BioSciences Acquires GQ Bio
HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...
Read more …
CrystalsFirst Scales Operations...
CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...
Read more …
Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT
medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...
Read more …